HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Burn, D J Articles by Jaros, E Search for Related Content PubMed PubMed Citation Articles by Burn, D J Articles by Jaros, E

Multiple system atrophy: cellular and molecular pathology

¹ Regional Neurosciences Centre, Newcastle General Hospital, Westgate Road, Newcastle upon Tyne NE4 6BE, UK
² Institute for the Health of the Elderly, Department of Neuropathology, Newcastle General Hospital

Correspondence: Dr Burn d.j.burn{at}ncl.ac.uk

Multiple system atrophy is an adult onset neurodegenerative disease, featuring parkinsonism, ataxia, and autonomic failure, in any combination. The condition is relentlessly progressive and responds poorly to treatment. Death occurs on average six to seven years after the onset of symptoms. No familial cases of multiple system atrophy have been reported, and no environmental factors have been robustly implicated as aetiological factors. However, analytical epidemiological studies are hampered because the condition is relatively rare. The discovery of the glial cytoplasmic inclusion (GCI) in 1989 helped to define multiple system atrophy as a clinicopathological entity, and drew attention to the prominent, if not primary, role played by the oligodendrocyte in the pathogenesis of the condition. Subsequently, GCIs were shown to be positive for -synuclein, with immunostaining for this protein indicating that white matter pathology was more widespread than had previously been recognised. The presence of -synuclein in GCIs provides a link with Parkinson's disease, dementia with Lewy bodies, and neurodegeneration with brain iron accumulation, type 1 (or Hallervorden-Spatz syndrome), in which -synuclein is also found within Lewy bodies. This has led to the term "synucleinopathy" to embrace this group of conditions. The GCIs of multiple system atrophy contain a range of other cytoskeletal proteins. It is unknown how fibrillogenesis occurs, and whether there is primary oligodendrocytic dysfunction, which then disrupts the neurone/axon as a consequence of the glial pathology, or whether the oligodendrocytic changes merely represent an epiphenomenon. Further research into this devastating condition is urgently needed to improve our understanding of the pathogenesis, and also to produce new treatment approaches.

Key Words: multiple system atrophy • glial cytoplasmic inclusion • -synuclein • oligodendrocyte

This article has been cited by other articles:

				C. W. Shults, E. Rockenstein, L. Crews, A. Adame, M. Mante, G. Larrea, M. Hashimoto, D. Song, T. Iwatsubo, K. Tsuboi, et al. Neurological and Neurodegenerative Alterations in a Transgenic Mouse Model Expressing Human {alpha}-Synuclein under Oligodendrocyte Promoter: Implications for Multiple System Atrophy J. Neurosci., November 16, 2005; 25(46): 10689 - 10699. [Abstract] [Full Text] [PDF]

				N. Stefanova, M. Reindl, M. Neumann, C. Haass, W. Poewe, P. J. Kahle, and G. K. Wenning Oxidative Stress in Transgenic Mice with Oligodendroglial {alpha}-Synuclein Overexpression Replicates the Characteristic Neuropathology of Multiple System Atrophy Am. J. Pathol., March 1, 2005; 166(3): 869 - 876. [Abstract] [Full Text] [PDF]

				M B Muzaimi, J Thomas, S Palmer-Smith, L Rosser, P S Harper, C M Wiles, D Ravine, and N P Robertson Population based study of late onset cerebellar ataxia in south east Wales J. Neurol. Neurosurg. Psychiatry, August 1, 2004; 75(8): 1129 - 1134. [Abstract] [Full Text] [PDF]

				A. RECCHIA, P. DEBETTO, A. NEGRO, D. GUIDOLIN, S. D. SKAPER, and P. GIUSTI {alpha}-Synuclein and Parkinson's disease FASEB J, April 1, 2004; 18(6): 617 - 626. [Abstract] [Full Text] [PDF]

				T. Liang, J. Spence, L. Liu, W. N. Strother, H. W. Chang, J. A. Ellison, L. Lumeng, T.-K. Li, T. Foroud, and L. G. Carr alpha -Synuclein maps to a quantitative trait locus for alcohol preference and is differentially expressed in alcohol-preferring and -nonpreferring rats PNAS, April 15, 2003; 100(8): 4690 - 4695. [Abstract] [Full Text] [PDF]